CT-P13 (Infliximab) Subcutaneous Administration by Pre-filled Syringe and Auto-injector in Healthy Subjects

NCT03446976 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

218

Enrollment

INDUSTRY

Sponsor class

Conditions

Health, Subjective

Interventions

BIOLOGICAL: CT-P13 SC Auto-injector
BIOLOGICAL: CT-P13 SC Pre-filled Syringe

Sponsor

Celltrion